Brain injuries, also known as traumatic brain injuries (TBIs), are caused by a physical trauma to the head or face area, resulting in permanent or temporary impairment of cognitive, physical, and psychosocial functions. They range from mild to severe, depending on the degree of neurological damage that has taken place. Common causes of TBIs include motor vehicle accidents, falls, sports injuries, assaults, and near-drowning incidents. In mild cases, a person may experience temporary dizziness, confusion, or loss of consciousness after an injury to the head. Severe brain injuries can result in major long-term physical, cognitive, and behavioural impairments. Cognitive effects can include speech and language delays, memory and concentration difficulties, slower reaction time, and impaired judgement. Physical effects can include vision problems, motor neurological deficits, and paralysis. Psychosocial effects can include emotional distress, difficulty establishing and maintaining relationships, and impairment of daily independent living skills. Prevention is the most effective way to reduce the risk of suffering a TBI. Protective safety gear such as helmets and activity-related safety equipment can greatly reduce the risk of any kind of physical trauma to the brain, while prioritizing safety awareness can help to reduce the risk of environmental hazards that could inflict a TBI in children and adults. Treatment of a brain injury is based on the severity of the injury and can range from observation to medication or surgery. Depending on the particular situation, the treatment plan may involve physical, occupational, speech, or psychological therapies, along with medications to reduce inflammation and swelling, improve brain function, and manage any emotional distress. For some severe cases, long-term rehabilitation may be necessary. Through supportive treatment tailored to each individual, survivors of TBIs may eventually sustain a high quality of life and independence.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States